We are an iconic provider of hospital-based healthcare, striving to deliver an exceptional standard of care
We comprise several hospitals, health centres, a nationally accredited education provider and a world-class research institute
We are a nationally accredited, hospital-based Registered Training Organisation - the only one of its kind in Queensland
We are part of a collaborative research institute with The University of Queensland and founding partner of the Translational Research Institute
Health . Education . Research . Foundation
After six years as Chair of Mater Misericordiae Ltd, businessman and philanthropist Brian Flannery has announced his retirement from the Mater Board.
Mr Peter Pearce and Sister Pauline Burke will also step down from their Mater Board roles at the November meeting. Having served the Board for significant terms, Mr Pearce for 15 years and Sister Pauline for 11 years, they have made considerable contributions to the growth and strategic direction of Mater.
An iconic provider of healthcare services in Queensland, Mater Group has grown to incorporate health, education and research businesses as well as other interests during the above mentioned directors tenure.
Having served as a Board Director for some 17 years, Mr Flannery reflected on a period of significant growth and change for Mater, and for the healthcare industry more broadly.
“Mater continues to play an important role in delivering outstanding healthcare for Queenslanders, and by integrating education and research, we have positioned ourselves to be more relevant in a changing world,” Mr Flannery said.
“I’m proud of what the Board has achieved in guiding Mater through challenging times and ensuring that our organisation can continue to deliver on our Mission, to meet unmet need.”
Mr Flannery was instrumental in the establishment of Mater Private Hospital Springfield as well as new Mater Mothers’ Hospitals and the transition of Mater Children’s Hospital to the Queensland Children’s Hospital.
He will leave Mater after the group’s Annual General Meeting in November, to be succeeded by current Deputy Chair, Mr Terry Crawford.
Mr Crawford has been a member of the Mater Board since 2011 and has extensive senior executive and director experience nationally and internationally, including prior roles as Head of International Strategy, and Head of Wealth Management Europe for HSBC Bank. He has been a director of government owned corporations, not-for-profit companies and commercial corporations for more than 20 years.
07 3163 1524
07 3163 6142
Some of the smallest people at Mater are learning how to make a big impact on the environment through a unique hands on learning program.
A new drug, yet to be approved by the Therapeutic Goods Administration, is giving a small group of chronic Cystic Fibrosis (CF) patients at Mater a second chance at life.
International Pathology Day is dedicated to highlighting the fundamental role that pathology and laboratory medicine services play in the healthcare community.
Shaun Lacey has been working in aged care for 25 years and shares his passion for the industry and why he loves helping students prepare for a rewarding career.